Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBA52P4 is a human pseudogene classified as a processed (retroposed) copy of the functional UBA52 gene, which encodes a fusion protein of ubiquitin and a 52-residue ribosomal protein[9][2][7]. UBA52P4 itself carries several nucleotide substitutions and deletions that disrupt its open reading frame, making it non-coding and non-functional[2]. This pseudogene does not produce any functional protein and has no established biological role, interactions, or therapeutic relevance[9][2][8][3][5]. It is not considered a receptor, enzyme, transporter, or any other canonical target class but is a member of the highly duplicated ribosomal protein/ubiquitin gene family[2][7]. No evidence links UBA52P4 directly with human disease or therapeutic intervention[9][2][3][5][8][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogene 4 (UBA52P4).